Your session is about to expire
← Back to Search
Herbal Supplement
Milk Thistle for Gambling Addiction
Phase 2
Waitlist Available
Led By Jon E Grant, JD, MD, MPH
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once every two weeks for the 8 weeks of the study
Awards & highlights
Study Summary
This trial will test if silymarin, a substance derived from milk thistle, is an effective and safe treatment for gambling disorder.
Eligible Conditions
- Gambling Addiction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ once every two weeks for the 8 weeks of the study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once every two weeks for the 8 weeks of the study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling (PG-YBOCS)
Secondary outcome measures
Clinical Global Impression-Improvement and Severity scales (CGI)
Gambling Symptom Assessment Scale (G-SAS)
Hamilton Anxiety Rating Scale (HAM-A)
+4 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Milk ThistleActive Control1 Intervention
Capsule form, 150mg BID to 300mg BID
Group II: PlaceboPlacebo Group1 Intervention
Matched dosage of milk thistle daily.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,734 Total Patients Enrolled
Jon E Grant, JD, MD, MPHPrincipal InvestigatorUniversity of Chicago
7 Previous Clinical Trials
834 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger